Related references
Note: Only part of the references are listed.Synthesis and bio-evaluation of indole-chalcone based benzopyrans as promising antiligase and antiproliferative agents
Sampa Gupta et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery of coumarin-dihydroquinazolinone analogs as niacin receptor 1 agonist with in-vivo anti-obesity efficacy
L. Ravithej Singh et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Novel pyrazolopyrimidines: Synthesis, in vitro cytotoxic activity and mechanistic investigation
Ghaneya S. Hassan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis and molecular docking of N′-arylidene-5-(4-chlorophenyl)-1-(3,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carbohydrazides as novel hypoglycemic and antioxidant dual agents
Eduardo Hernandez-Vazquez et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Synthesis and biological evaluation of novel pyrazolopyrimidines derivatives as anticancer and anti-5-lipoxygenase agents
Ameur Rahmouni et al.
BIOORGANIC CHEMISTRY (2016)
A Catalyst-Free One-Pot Protocol for the Construction of Substituted Isoindolinones under Sustainable Conditions
Koneni V. Sashidhara et al.
SYNLETT (2016)
Design, synthesis and biological evaluation of novel pyrazolo-pyrimidinones as DPP-IV inhibitors in diabetes
Sneha R. Sagar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Iodine Catalyzed Oxidative Synthesis of Quinazolin-4(3H)-ones and Pyrazolo[4,3-d]pyrimidin-7(6H)-ones via Amination of sp3 C-H Bond
Shabber Mohammed et al.
JOURNAL OF ORGANIC CHEMISTRY (2015)
In vitro anti-hyperglycemic activity of 4-hydroxyisoleucine derivatives
Venkateswarlu Korthikunta et al.
PHYTOMEDICINE (2015)
Discovery of pyrazolo[3,4-d]pyrimidine derivatives as GPR119 agonists
Paul Gillespie et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Dipeptidyl Peptidase IV and Its Inhibitors: Therapeutics for Type 2 Diabetes and What Else?
Lucienne Juillerat-Jeanneret
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Potent and Orally Bioavailable GPR142 Agonists as Novel Insulin Secretagogues for the Treatment of Type 2 Diabetes
Narihiro Toda et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Chemical constituents of Kigelia pinnata twigs and their GLUT4 translocation modulatory effect in skeletal muscle cells
Mohammad Faheem Khan et al.
FITOTERAPIA (2012)
Balaglitazone: A Second Generation Peroxisome Proliferator-Activated Receptor (PPAR) Gamma (γ) Agonist
R. Agrawal et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)
Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin
U. Graefe-Mody et al.
DIABETES OBESITY & METABOLISM (2011)
PPARs: diverse regulators in energy metabolism and metabolic diseases
Yong-Xu Wang
CELL RESEARCH (2010)
Synthesis and antitumor activity of novel 6-aryl and 6-alkylpyrazolo[3,4-d] pyrimidin-4-one derivatives
Mervat M. El-Enany et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors
F. Gellibert et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Type 2 diabetes: Where we are today: An overview of disease burden, current treatments, and treatment strategies
R. Keith Campbell
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2009)
IRS1-independent defects define major nodes of insulin resistance
Kyle L. Hoehn et al.
CELL METABOLISM (2008)
A catalytic method for synthesis of 6-aryl-1H-pyrazolo[3,4-d]pyrimidin-4[5H]-ones by heteropolyacids:: H14[NaP5W29MoO110] and H3PMo12O40
Majid M. Heravi et al.
CATALYSIS COMMUNICATIONS (2007)
Facile synthesis of pyrazolo[3,4-d]pyrimidines and pyrimido[4,5-d]pyrimidin-4-one derivatives
Sanjay Babu Katiyar et al.
SYNTHETIC COMMUNICATIONS (2006)
Synthesis and biological evaluation of 1-aryl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of cyclin-dependent kinases
JA Markwalder et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins
IS Wood et al.
BRITISH JOURNAL OF NUTRITION (2003)
Free fatty acids in obesity and type 2 diabetes:: defining their role in the development of insulin resistance and β-cell dysfunction
G Boden et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2002)
Share Paper
